ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,031.25
      1.36%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kazia Therapeutics Ltd (KZIA)

      7. Kazia Therapeutics Ltd (KZIA) News

      KZIA

      Kazia Therapeutics (KZIA)

      Kazia Therapeutics Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KZIA
      DateTimeSourceHeadlineSymbolCompany
      04/02/20096:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      03/23/20095:19PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      03/23/200910:46AMMarketwiredBoard Changes at Novogen Limited AnnouncedNASDAQ:KZIAKazia Therapeutics Ltd
      03/20/20091:21PMEdgar (US Regulatory)Amended Annual and Transition Report (foreign private issuer) (20-F/A)NASDAQ:KZIAKazia Therapeutics Ltd
      03/19/20091:06PMMarketwiredBiotech Analyst Joins Board of Directors of Marshall Edwards, Inc.NASDAQ:KZIAKazia Therapeutics Ltd
      03/18/200911:15AMMarketwiredNovogen's NV-128 Targets the mTOR Pathway to Induce Cell Death in Epithelial Ovarian Cancer Stem CellsNASDAQ:KZIAKazia Therapeutics Ltd
      03/18/20099:21AMMarketwiredTriphendiol Safety Data Clears the Way for Compound to Be Studied Further in the Treatment of Pancreatic CancerNASDAQ:KZIAKazia Therapeutics Ltd
      03/18/20097:52AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      03/18/20097:50AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      02/27/20095:26PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      02/24/20095:15PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      02/24/20098:00AMMarketwiredYale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary CNASDAQ:KZIAKazia Therapeutics Ltd
      02/17/20096:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      02/13/20099:27AMMarketwiredNovogen to Focus on Oncology ProgramNASDAQ:KZIAKazia Therapeutics Ltd
      01/14/20098:59AMMarketwiredMarshall Edwards, Inc. to Present at the 27th Annual JPMorgan Healthcare ConferenceNASDAQ:KZIAKazia Therapeutics Ltd
      01/07/20098:10AMMarketwiredMarshall Edwards, Inc. Granted IND for TriphendiolNASDAQ:KZIAKazia Therapeutics Ltd
      01/07/20096:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      12/19/20088:15AMMarketwiredMarshall Edwards, Inc. Announces Resignation of Stephen Breckenridge From Board of Directors and Appointment of William RueckertNASDAQ:KZIAKazia Therapeutics Ltd
      12/05/20088:01AMEdgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:KZIAKazia Therapeutics Ltd
      12/01/20088:10AMMarketwiredMarshall Edwards, Inc. Files IND Application for TriphendiolNASDAQ:KZIAKazia Therapeutics Ltd
      12/01/20088:10AMMarketwiredNovogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem CellsNASDAQ:KZIAKazia Therapeutics Ltd
      12/01/20086:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      12/01/20086:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      11/18/20086:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      11/13/20088:10AMMarketwiredIndependent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial ContinueNASDAQ:KZIAKazia Therapeutics Ltd
      11/12/20088:10AMMarketwiredIndependent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial ContinueNASDAQ:KZIAKazia Therapeutics Ltd
      11/05/20085:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      11/03/20086:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      11/03/20086:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
      10/30/20087:18PMMarketwiredMarshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer ActNASDAQ:KZIAKazia Therapeutics Ltd
       Showing the most relevant articles for your search:NASDAQ:KZIA